Resources
The latest in cell & gene research, from advanced therapies through to the latest developments in cell & gene research, therapies & manufacturing
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Cell Therapy Development
Good Manufacturing Practices: Overcoming Regulatory Approval Hurdles
Securing regulatory approval is often the end goal in the development of a new therapeutic product. But what steps can be taken to avoid some of the common curveballs encountered in the industry?
Tissue Engineering & 3D Models
In Conversation With...Stefan Przyborski, Professor, Durham University
In this video Q&A we discuss Stefan's recent work with bioengineered human tissues and the challenges to adopting 3D cell culture technologies in research.
Tissue Engineering & 3D Models
Apical-Out Organoids: A Novel Strategy to Control the Polarity of Organoids Closing
Genentech are developing several complex gastrointestinal in vitro models, including the innovative apical-out organoids.
Cell & Gene Therapy Manufacturing
Q &A with Shilpi Rajoria
An interview Shilpi Rajoria, Director QC Analytical Testing at Bristol Myers Squibb.
Tissue Engineering & 3D Models
Understanding the Capabilities of 3D Bioprinting for Cell and Gene Therapy
Exploring academic perspectives on 3D bioprinting techniques for cancer and disease indication models.
Tissue Engineering & 3D Models
Advanced and Predictive 3D Cell Culture Models
Elodie Vandenhaute, Project Director at HCS Pharma, leads a discussion group on utilising multi-cell type models to understand diseases, cells, and therapeutic mechanisms.
Upstream & Downstream Bioprocessing
Accelerating Upstream Process Development with Direct CQA and Media Analysis Feedback
Upstream Bioprocess Development.
Cell Line Development & Engineering
Experience the Next Generation in Clonality
Explore the future of single cell seeding.
Tissue Engineering & 3D Models
Using Cancer Organoids to Discover New Therapeutic Targets
The lack of predictive models is a highly limiting factor in the efficacy of projects designed to find new therapeutic targets. Cutting-edge organoid models may be the key to overcoming these challenges and could improve the prediction candidate drug molecules' clinical success.
Cell & Gene Therapy Manufacturing
Overcoming the Challenges in Cell Therapy Manufacturing
Udayanath Aich, Director at Bristol Myers Squibb, leads a Discussion Group on leveraging advanced technologies and biologics to mitigate challenges.
Cell & Gene Therapy Manufacturing
Looking into the Crystal Ball: The Future of Disruptive Cell and Gene Therapy Manufacturing
What will the future hold for autologous cell and gene therapy manufacturing? Tigen Pharma SA, share their predictions on the prospect of disruptive innovation for the industry.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things cell & gene